Product
AI AGENTS
INTELLIGENCE SUITE
API, MCP & INTEGRATION
Solutions
INDUSTRIES
USE CASES
Pricing
Resources
EXPLORE
ENGAGE
SUPPORT & SERVICES
About
Patsnap Eureka Platform
IP Search Agents
IP Drafting Agents
Engineering Agents
Find Solutions with TRIZ
Life Sciences Agents
Materials Agents
SEP Agents
Patsnap Eureka Desktop
BetaAnalytics
IP IntelligenceSynapse
Biopharma IntelligenceBio
Biosequence Search and AnalysisChemical
Chemical Structure Search and AnalysisProfessional Services
Open Platform
Developer Center
Customer Stories
Newsroom
Blog
Global Innovation Report
Glossary
Webinars & Training
User Community
R&D Benchmark Calculator
Trust and Security
PatentBench
NEWLLM
Help center
Careers
Access to over 2,000,000,000 structured data points around patents, science, litigation, and tech sectors
Innovate 75% faster at 25% less cost
Cloud or on-prem for maximum privacy and control
Trusted by more than 18,000 innovators worldwide
To use , click the vertification button in the email we sent to [email protected].
This helps keep your account secure.
You should receive it shortly. Don’t forget to check your spam folder.
Unlock professional features and history
Already have an account? Log In
To start using Patsnap Eureka, click the verification button in the email we sent to .
This helps keep your account secure.
Haven't received it? Check your spam folder.
Thoughtfully curated series offering valuable insights for innovation professionals
Article | Report Explore the 2026 thermoelectric module packaging landscape: hermetic encapsulation, flexible substrates, IC spot-cooling, and key patent assignees from Kyocera to Google.
Article | Report How cryo-EM reveals atomic-scale SEI nanostructure in next-generation batteries — key findings on Li₂CO₃ stability, 3D conformality, and sodium systems.
Article | Report How LNP-delivered mRNA and engineered viral vectors are reshaping CAR-T therapy by programming T cells directly inside the body — bypassing costly ex vivo manufacturing.
Article | Report Microrobotic drug delivery is approaching clinical translation. Explore propulsion mechanisms, application domains, geographic leaders, and emerging IP opportunities in this 2026 landscape.
Article | Report How do hot carrier injection and bias temperature instability differ as dominant aging mechanisms at 3nm? Physics, scaling behavior, and coupled interactions explained.
Article | Report Explore the dendritic cell vaccine therapy pipeline in solid tumors: personalized antigen loading, mRNA electroporation, DC-tumor fusion, and checkpoint combination strategies.
Article | Report Explore the 2026 metal hydride heat pump technology landscape: patent clusters, dual-bed reactors, EV cooling, CSP storage, and key IP white spaces.
Article | Report How hydrogen diffusion degrades gate oxide dielectric breakdown lifetime under bias temperature stress—and the engineering strategies that prevent it.
Article | Report How iPSC-derived dopaminergic neuron therapies—autologous and off-the-shelf—are reshaping the Parkinson's disease cell therapy pipeline. Key preclinical data, institutions, and strategic signals.
Article | Report Explore the 2026 MPI technology landscape: hardware advances, SPION tracer design, image reconstruction, and clinical translation pathways across 2013–2025 patent and literature data.
Article | Report How does plasma doping compare to beam-line ion implantation for ultra-shallow junction formation in sub-5nm FinFETs? A technical analysis of conformality, damage, and emerging alternatives.
Article | Report iPSC-derived cardiomyocyte therapy for heart failure: pipeline analysis covering cell patches, 3D constructs, EVs, and the Osaka first-in-human trial.
Article | Report Nanopore DNA sequencing has evolved from lab curiosity to clinical platform. Explore the 2026 technology landscape: key patents, basecalling AI, and IP white space.
Article | Report Positive vs. negative tone development for EUV resist patterning at advanced nodes: developer chemistry, LWR, resolution, and RLS trade-offs compared.
Article | Report Stapled peptides, cyclic peptides, and CPP conjugates are unlocking undruggable PPI targets. Explore the patent and clinical signals shaping the peptide drug pipeline.